Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA VENOUS DISEASES TREATMENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET END USER COVERAGE GRID
2.8 INSTRUMENT BASED LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
5 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, INDUSTRY INSIGHTS
6 EPIDEMIOLOGY
7 REGULATORY FRAMEWORK
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 RISING INCIDENCES OF VENOUS DISEASES
8.1.2 RAPID CHANGES IN LIFESTYLE LEAD TO OBESITY RESULTING IN VENOUS DISEASES
8.1.3 INCREASE IN THE GERIATRIC POPULATION
8.1.4 TECHNOLOGICALLY ADVANCEMENT IN THE TREATMENT OF VENOUS DISEASES
8.2 RESTRAINTS
8.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
8.2.2 INADEQUATE REIMBURSEMENT COVERAGE
8.3 OPPORTUNITIES
8.3.1 RISING AWARENESS TOWARDS VENOUS DISORDERS
8.3.2 NEED FOR PROPER DIAGNOSIS AND TREATMENT OF VENOUS DISEASES
8.3.3 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES
8.3.4 OCCUPATIONAL LIFESTYLE INCREASES THE NEED FOR VENOUS DISEASE TREATMENT
8.4 CHALLENGES
8.4.1 HIGH COST ASSOCIATED WITH VENOUS DISEASE TREATMENT
8.4.2 SIDE EFFECTS AND RISK ASSOCIATED WITH DIFFERENT TREATMENT MODES
9 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE
9.1 OVERVIEW
9.2 SCLEROTHERAPY INJECTION
9.2.1 SCLEROTHERAPY, BY TYPE
9.2.1.1 INTRAVENOUS
9.2.1.2 INTRADERMAL
9.2.1.3 SUBCUTANEOUS
9.2.2 SUBCUTANEOUS, BY APPLICATION
9.2.2.1 MALFORMED LYMPHED VESSELS
9.2.2.2 HEMORRHOIDS
9.2.2.3 HYDROCELES
9.2.2.4 OTHERS
9.3 ABLATION DEVICES
9.3.1 THERMAL ABLATION
9.3.1.1 RADIOFREQUENCY
9.3.1.1.1 CATHETER MANIPULATION SYSTEMS
9.3.1.1.2 TEMPERATURE CONTROLLED
9.3.1.1.3 FLUID COOLED
9.3.1.2 LIGHT
9.3.1.2.1 EXCIMER LASERS
9.3.1.2.2 COLD LASERS
9.3.1.3 ULTRASOUND
9.3.1.3.1 HIGH INTENSITY FOCUSED ULTRASOUND (HIFU)
9.3.1.3.2 SHOCK WAVE LITHOTRIPSY
9.3.1.3.3 MAGNETIC RESONANCE IMAGING GUIDED FOCUSED ULTRASOUND (MRI-FUS)
9.3.1.3.4 ULTRASONIC SURGICAL SYSTEMS
9.3.1.4 RADIATION
9.3.1.4.1 STEREOTACTIC BODY RADIATION THERAPY
9.3.1.4.2 INTENSITY-MODULATED RADIATION THERAPY
9.3.1.4.3 STEREOTACTIC RADIOTHERAPY & RADIOSURGERY
9.3.1.4.4 IMAGE GUIDED RADIATION THERAPY
9.3.1.4.5 INTRAVASCULAR BRACHYTHERAPY
9.3.1.4.6 PROTON BEAM THERAPY
9.3.1.5 ELECTRICAL
9.3.1.5.1 ELECTRICAL ABLATORS
9.3.1.5.2 ELECTRONIC BRACHYTHERAPY
9.3.1.6 MICROWAVE
9.3.1.7 HYDROTHERMAL
9.3.2 NON-THERMAL ABLATION
9.3.2.1 CRYOABLATION
9.3.2.1.1 EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES
9.3.2.1.2 CRYOGEN SPRAY PROBE
9.3.2.1.3 TISSUE CONTACT PROBE
9.3.2.2 HYDROMECHANICAL ABLATION
9.4 VENOUS CLOSURE PRODUCTS
9.4.1 VENOUS CLOSURE PRODUCTS, BY PROCEDURE
9.4.1.1 INTERVENTIONAL CARDIOLOGY
9.4.1.2 INTERVENTIONAL RADIOLOGY
9.4.2 VENOUS CLOSURE PRODUCTS, BY TECHNOLOGY
9.4.2.1 FEMORAL ACCESS TECHNIQUE
9.4.2.2 RADIAL ACCESS TECHNIQUE
9.5 VENOUS STENTS
9.5.1 VENOUS STENTS, BY TECHNOLOGY
9.5.1.1 WALLSTENT TECHNOLOGY
9.5.1.2 ILIAC VEIN STENT TECHNOLOGY
9.5.2 VENOUS STENTS, BY APPLICATION
9.5.2.1 LEG
9.5.2.2 CHEST
9.5.2.3 ABDOMEN
9.5.2.4 OTHERS
9.6 MEDICATION
9.7 OTHERS
10 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE
10.1 OVERVIEW
10.2 VARICOSE VEINS
10.3 DEEP VEIN THROMBOSIS (DVT)
10.4 PULMONARY EMBOLISM
10.5 CHRONIC VENOUS INSUFFICIENCY (CVI)
10.6 SUPERFICIAL THROMBOPHLEBITIS
10.7 OTHERS
11 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE
11.1 OVERVIEW
11.2 SCLEROTHERAPY
11.3 RADIOFREQUENCY ABLATION THERAPY
11.4 LASER TREATMENT
11.5 AMBULATORY PHLEBECTOMY
11.6 VEIN LIGATION AND STRIPPING
11.7 ANGIOPLASTY OR STENTING
11.8 SURGERIES
11.9 COMPRESSION THERAPY
11.1 VEINACTIVE MEDICATION
11.11 VENA CAVA FILTER
11.12 OTHER THERAPIES
12 NORTH AMERICA VENOUS TREATMENT DISEASES MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.3 CLINICS
12.4 AMBULATORY SURGICAL CENTERS
12.5 OTHERS
13 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 RETAIL SALES
13.4 OTHERS
14 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY REGION
14.1 NORTH AMERICA
14.1.1 U.S.
14.1.2 CANADA
14.1.3 MEXICO
15 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 MEDTRONIC
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENTS
17.2 BOSTON SCIENTIFIC CORPORATION
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 VARIAN MEDICAL SYSTEMS, INC.
17.3.1 COMPANY SNAPSHOT
17.3.2 COMPANY SHARE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENT
17.4 STRYKER
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENT
17.5 KONINKLIJKE PHILIPS N.V.
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 COMPANY SHARE ANALYSIS
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENT
17.6 ABBOTT
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 ALMA LASERS
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENT
17.8 ANGIODYNAMICS
17.8.1 COMPANY SNAPSHOT
17.8.2 REVENUE ANALYSIS
17.8.3 PRODUCT PORTFOLIO
17.8.4 RECENT DEVELOPMENT
17.9 B.BRAUN MELSUNGEN AG
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENTS
17.1 BAYLIS MEDICAL COMPANY, INC
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 BD
17.11.1 COMPANY SNAPSHOT
17.11.2 REVENUE ANALYSIS
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENT
17.12 CANDELA MEDICAL
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 CARL ZEISS MEDITEC AG
17.13.1 COMPANYSNAPSHOT
17.13.2 REVENUE ANALYSIS
17.13.3 PRODUCT PORTFOLIO
17.13.4 RECENT DEVELOPMENT
17.14 COOK
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENTS
17.15 IMRICOR
17.15.1 COMPANY SNAPSHOT
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENT
17.16 OLYMPUS CORPORATION
17.16.1 COMPANY SNAPSHOT
17.16.2 REVENUE ANALYSIS
17.16.3 PRODUCT PORTFOILIO
17.16.4 RECENT DEVELOPMENT
17.17 OPTIMED MEDIZINISCHE INSTRUMENTE GMBH
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENTS
17.18 PLUSMEDICA.DE
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 SCITECH
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENTS
17.2 SMITH + NEPHEW
17.20.1 COMPANY SNAPSHOT
17.20.2 REVENUE ANALYSIS
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENT
17.21 SONABLATE
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENT
17.22 THERACLION
17.22.1 COMPANY SNAPSHOT
17.22.2 REVENUE ANALYSIS
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENT
17.23 TELEFLEX INCORPORATED
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENTS
17.24 TERUMO CORPORATION
17.24.1 COMPANY SNAPSHOT
17.24.2 REVENUE ANALYSIS
17.24.3 PRODUCT PORTFOLIO
17.24.4 RECENT DEVELOPMENTS
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 NORTH AMERICA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 NORTH AMERICA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 4 NORTH AMERICA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 14 NORTH AMERICA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 15 NORTH AMERICA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 NORTH AMERICA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 17 NORTH AMERICA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 18 NORTH AMERICA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 NORTH AMERICA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 20 NORTH AMERICA ILIAC VEIN STENT TECHNOLOGY IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 21 NORTH AMERICA MEDICATION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 NORTH AMERICA OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA VARICOSE VEINS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA DEEP VEIN THROMBOSIS (DVT) IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA PULMONARY EMBOLISM IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA CHRONIC VENOUS INSUFFICIENCY (CVI) IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA SUPERFICIAL THROMBOPHLEBITIS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 31 NORTH AMERICA SCELEROTHERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 NORTH AMERICA RADIOFREQUENCY ABLATION THERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 NORTH AMERICA LASER TREATMENT IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 34 NORTH AMERICA AMBULATORY PHELEBECTOMY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 35 NORTH AMERICA VEIN LIGATION AND STRIPPING IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 NORTH AMERICA ANGIOPLASTY OR STENTING IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 37 NORTH AMERICA SURGERIES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 NORTH AMERICA COMPRESSION THERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 NORTH AMERICA VEINACTIVE MEDICATION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 40 NORTH AMERICA VENA CAVA FILTER IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 41 NORTH AMERICA OTHER THERAPIES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 43 NORTH AMERICA HOSPITALS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 44 NORTH AMERICA CLINICS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 45 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 46 NORTH AMERICA OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 47 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 48 NORTH AMERICA DIRECT TENDER IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 49 NORTH AMERICA RETAIL SALES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 50 NORTH AMERICA OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 51 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 52 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 53 NORTH AMERICA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 54 NORTH AMERICA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 55 NORTH AMERICA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 56 NORTH AMERICA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 57 NORTH AMERICA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 58 NORTH AMERICA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 59 NORTH AMERICA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 60 NORTH AMERICA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 61 NORTH AMERICA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 62 NORTH AMERICA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 63 NORTH AMERICA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 NORTH AMERICA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 65 NORTH AMERICA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 66 NORTH AMERICA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 67 NORTH AMERICA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 68 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 69 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 70 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 71 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 72 U.S. VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 73 U.S. SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 74 U.S. SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 75 U.S. ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 76 U.S. THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 77 U.S. RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 78 U.S. LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 79 U.S. ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 80 U.S. RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 81 U.S. ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 82 U.S. NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 83 U.S. CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 84 U.S. VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 85 U.S. VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 86 U.S. VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 87 U.S. VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 88 U.S. VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 89 U.S. VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 90 U.S. VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 91 U.S. VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 92 CANADA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 93 CANADA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 94 CANADA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 95 CANADA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 96 CANADA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 97 CANADA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 98 CANADA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 99 CANADA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 100 CANADA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 101 CANADA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 102 CANADA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 103 CANADA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 104 CANADA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 105 CANADA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 106 CANADA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 107 CANADA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 108 CANADA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 109 CANADA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 110 CANADA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 111 MEXICO VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 112 MEXICO SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 113 MEXICO SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 114 MEXICO ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 115 MEXICO THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 116 MEXICO RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 117 MEXICO LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 118 MEXICO ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 119 MEXICO RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 120 MEXICO ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 121 MEXICO NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 122 MEXICO CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 123 MEXICO VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 124 MEXICO VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 125 MEXICO VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 126 MEXICO VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 127 MEXICO VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 128 MEXICO VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 129 MEXICO VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 130 MEXICO VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: SEGMENTATION
FIGURE 11 GROWING AWARENESS ABOUT VENOUS DISEASES TREATMENTS AND INCREASING HEALTHCARE EXPENDITURE IS EXPECTED TO DRIVE THE GROWTH OF THE NORTH AMERICA VENOUS DISEASES TREATMENT MARKET FROM 2023 TO 2030
FIGURE 12 THE ABLATION DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA VENOUS DISEASES TREATMENT MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE NORTH AMERICA VENOUS DISEASES TREATMENT MARKET
FIGURE 14 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, 2022
FIGURE 15 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, 2022
FIGURE 19 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, 2023-2030 (USD MILLION)
FIGURE 20 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, CAGR (2023-2030)
FIGURE 21 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, LIFELINE CURVE
FIGURE 22 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, 2022
FIGURE 23 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, 2023-2030 (USD MILLION)
FIGURE 24 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, CAGR (2023-2030)
FIGURE 25 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, LIFELINE CURVE
FIGURE 26 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY END USER, 2022
FIGURE 27 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: SNAPSHOT (2022)
FIGURE 35 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022)
FIGURE 36 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: PRODUCT TYPE (2023-2030)
FIGURE 39 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: COMPANY SHARE 2022 (%)
